Regadenoson use for stress myocardial perfusion imaging in advance chronic kidney disease and dialysis: Safe, effective, and efficient

J Nucl Cardiol. 2018 Feb;25(1):150-152. doi: 10.1007/s12350-017-1038-1. Epub 2017 Aug 14.

Authors

Ankur Gupta¹, Navkaranbir S Bajaj²

Affiliations

¹ Division of Cardiovascular Medicine and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, ASB-L1 037C, 75 Francis Street, Boston, MA, 02115, USA. agupta@bwh.harvard.edu.
² Division of Cardiovascular Medicine and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, ASB-L1 037C, 75 Francis Street, Boston, MA, 02115, USA.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Kidney Failure, Chronic*
Myocardial Perfusion Imaging*
Purines
Pyrazoles
Renal Dialysis

Substances

Purines
Pyrazoles
regadenoson

Grants and funding

T32 HL094301/HL/NHLBI NIH HHS/United States